- Patent Title: Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders
-
Application No.: US16513672Application Date: 2019-07-16
-
Publication No.: US10766943B2Publication Date: 2020-09-08
- Inventor: Michael Bachmann , Armin Ehninger
- Applicant: GEMoaB Monoclonals GmbH
- Applicant Address: DE Dresden
- Assignee: GEMoaB Monoclonals GmbH
- Current Assignee: GEMoaB Monoclonals GmbH
- Current Assignee Address: DE Dresden
- Agency: FisherBroyles, LLP
- Agent Andrew K. Gonsalves, Esq.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7cd0e204
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/725 ; C07K16/18 ; A61K35/17
Abstract:
The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.
Public/Granted literature
Information query
